Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Spatiotemporal Thalamocortical Alterations Underlie Experimental and Chronic Pain - Phase II

NCT06968689 is registered in ClinicalTrials.gov with The University of Texas Health Science Center, Houston as lead sponsor.

NCT NCT06968689
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06968689 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Spatiotemporal Thalamocortical Alterations Underlie Experimental and Chronic Pain - Phase II
Lead sponsor
The University of Texas Health Science Center, Houston
Phase
Not applicable
Overall status
Recruiting
Start date
June 1, 2025
Completion date
February 29, 2028
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pain